TREAT-NMD is a European neuromuscular network addressing the fragmentation currently hindering translational research for cutting edge therapies in rare neuromuscular diseases (NMD). It will strengthen European excellence in the treatment of rare NMD. Bringing promising cutting edge therapies into clinical settings is currently delayed by the lack of standardised protocols for preclinical animal studies, molecular diagnoses and patient assessment and management. TREAT-NMD will address this fragmentation by establishing a common road map for the progression of cutting edge therapies from laboratory to clinic, from the assessment of cellular and animal models, via issues of delivery, production and toxicology, to clinical outcome measur...
Clinical trials for rare neuromuscular diseases imply, among other investments, a high emotional bur...
The rapidly expanding knowledge of NMDs genetic diagnosis, pathogenesis and therapeutic possibilitie...
Abstract Neuromuscular disorders (NMD) are a heterogeneous group of genetic conditions, with autosom...
International audienceDuchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by th...
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of the dystr...
<p>Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of ...
<p>Established in 2007 in the scope of the TREAT-NMD project (EU-funded Network of Excellence, FP6) ...
Treat-NMD is an international collaboration aimed at bringing treatments to people with neuromu...
Clinical trials for rare neuromuscular diseases imply, among other investments, a high emotional bur...
Symposium C2: Theme: Neurology 2 - Neuromuscular Disoder, the Treatment, the Multidisciplinary Care ...
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder characterized by a loss of mo...
A workshop took place in 2015 to follow up TREAT-NMD activities dedicated to improving quality in th...
A workshop took place in 2015 to follow up TREAT-NMD activities dedicated to improving quality in th...
Neuromuscular disorders (NMDs) encompass a diverse group of genetic diseases characterized by loss o...
Full title: Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of th...
Clinical trials for rare neuromuscular diseases imply, among other investments, a high emotional bur...
The rapidly expanding knowledge of NMDs genetic diagnosis, pathogenesis and therapeutic possibilitie...
Abstract Neuromuscular disorders (NMD) are a heterogeneous group of genetic conditions, with autosom...
International audienceDuchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by th...
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of the dystr...
<p>Duchenne muscular dystrophy (DMD) is an X-linked genetic disease, caused by the absence of ...
<p>Established in 2007 in the scope of the TREAT-NMD project (EU-funded Network of Excellence, FP6) ...
Treat-NMD is an international collaboration aimed at bringing treatments to people with neuromu...
Clinical trials for rare neuromuscular diseases imply, among other investments, a high emotional bur...
Symposium C2: Theme: Neurology 2 - Neuromuscular Disoder, the Treatment, the Multidisciplinary Care ...
Spinal muscular atrophy (SMA) is a rare genetic neuromuscular disorder characterized by a loss of mo...
A workshop took place in 2015 to follow up TREAT-NMD activities dedicated to improving quality in th...
A workshop took place in 2015 to follow up TREAT-NMD activities dedicated to improving quality in th...
Neuromuscular disorders (NMDs) encompass a diverse group of genetic diseases characterized by loss o...
Full title: Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of th...
Clinical trials for rare neuromuscular diseases imply, among other investments, a high emotional bur...
The rapidly expanding knowledge of NMDs genetic diagnosis, pathogenesis and therapeutic possibilitie...
Abstract Neuromuscular disorders (NMD) are a heterogeneous group of genetic conditions, with autosom...